P1311: LONG-TERM SAFETY AND EFFICACY OF EXTRACORPOREAL PHOTOPHERESIS AS EARLY SECOND-LINE TREATMENT FOR PATIENTS WITH STEROID-DEPENDENT OR REFRACTORY ACUTE GRAFT-VERSUS-HOST DISEASE.
Eleni Gavriilaki(Aristotle University of Thessaloniki), Ioanna Sakellari(G. Papanikolaou General Hospital), Nikolaos Spyridis(G. Papanikolaou General Hospital), Eleni Papchianou(G. Papanikolaou General Hospital), Christos Demosthenous(G. Papanikolaou General Hospital), Ioannis Batsis(G. Papanikolaou General Hospital), Georgios Karavalakis(University of California, Riverside), Αchilles Anagnostopoulos(G. Papanikolaou General Hospital), Anna Vardi(G. Papanikolaou General Hospital), Damianos Sotiropoulos(G. Papanikolaou General Hospital), Evangelia Yannaki(G. Papanikolaou General Hospital), Aikaterini Soulani(G. Papanikolaou General Hospital), Despina Mallouri(G. Papanikolaou General Hospital), Asimina Bouinta(G. Papanikolaou General Hospital), Alkistis Panteliadou(G. Papanikolaou General Hospital), Zoi Bousiou(G. Papanikolaou General Hospital)
Cited by 0
Related Papers
Is there a role for antigen selection in mantle cell lymphoma? Immunogenetic support from a series of 807 cases
|Blood|2011|178
COVID-19 severity and mortality in patients with CLL: an update of the international ERIC and Campus CLL study
|Leukemia|2021|94
Immunogenetics shows that not all MBL are equal: the larger the clone, the more similar to CLL
|Blood|2013|93
Genetic prediction of ICU hospitalization and mortality in COVID‐19 patients using artificial neural networks
|Journal of Cellular and Molecular Medicine|2022|90
Genetic justification of severe COVID-19 using a rigorous algorithm
|Clinical Immunology|2021|63